title: Alpha-aminoazaheterocyclic-methylglyoxal adducts do not inhibit cystic fibrosis transmembrane conductance regulator chloride channel activity.
abstract: Inhibitors of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel have potential applications in the therapy of secretory diarrheas and polycystic kidney disease. In a recent study, several highly polar alpha-aminoazaheterocyclic-methylglyoxal adducts were reported to reversibly inhibit CFTR chloride channel activity with IC50 values in the low picomolar range (J Pharmacol Exp Ther 322:1023-1035, 2007), more than 10,000-fold better than that of thiazolidinone and glycine hydrazide CFTR inhibitors previously identified by high-throughput screening. In this study, we resynthesized and evaluated the alpha-aminoazaheterocyclic-methylglyoxal adducts reported to have high CFTR inhibition potency (compounds 5, 7, and 8). We verified that the reported synthesis procedures produced the target compounds in high yield. However, we found that these compounds did not inhibit CFTR chloride channel function in multiple cell lines at up to 100 microM concentration, using three independent assays of CFTR function including short-circuit current analysis, whole-cell patch-clamp experiments, and yellow fluorescence protein-fluorescence quenching. As positive controls, approximately 100% of CFTR inhibition was found by thiazolidinone and glycine hydrazide CFTR inhibitors. Our data provide direct evidence against CFTR inhibition by alpha-aminoazaheterocyclic-methylglyoxal adducts.
authors.affiliation: Departments of Medicine and Physiology, 1246 Health Sciences East Tower, University of California, San Francisco, CA 94143-0521, USA.
authors.forename: N D
authors.initials: ND
authors.lastname: Sonawane
authors.forename: Olga
authors.initials: O
authors.lastname: Zegarra-Moran
authors.forename: Wan
authors.initials: W
authors.lastname: Namkung
authors.forename: Luis J V
authors.initials: LJ
authors.lastname: Galietta
authors.forename: A S
authors.initials: AS
authors.lastname: Verkman
mesh_terms: D000818:Animals; D001980:Bronchi / Q000166:cytology; D016466:CHO Cells; D002478:Cells, Cultured; D006224:Cricetinae; D003412:Cricetulus; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D004847:Epithelial Cells / Q000502:physiology; D006571:Heterocyclic Compounds / Q000378:metabolism*; D006801:Humans; D007082:Ileum / Q000502:physiology; D051379:Mice; D011765:Pyruvaldehyde / Q000378:metabolism*; D051381:Rats; D014162:Transfection
chemical_list: C505032:CFTR protein, human; D006571:Heterocyclic Compounds; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D011765:Pyruvaldehyde